Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Axsome Therapeutics (AXSM) Asset Utilization Ratio (2023 - 2026)

Axsome Therapeutics' Asset Utilization Ratio history spans 4 years, with the latest figure at 1.01 for Q1 2026.

  • On a quarterly basis, Asset Utilization Ratio rose 87.33% to 1.01 in Q1 2026 year-over-year; TTM through Mar 2026 was 1.01, a 87.33% increase, with the full-year FY2025 number at 1.01, up 52.18% from a year prior.
  • Asset Utilization Ratio hit 1.01 in Q1 2026 for Axsome Therapeutics, up from 0.94 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for AXSM hit a ceiling of 1.01 in Q1 2026 and a floor of 0.36 in Q2 2023.
  • Historically, Asset Utilization Ratio has averaged 0.57 across 4 years, with a median of 0.53 in 2024.
  • Biggest five-year swings in Asset Utilization Ratio: grew 4.0% in 2024 and later soared 98.51% in 2025.
  • Tracing AXSM's Asset Utilization Ratio over 4 years: stood at 0.46 in 2023, then grew by 4.0% to 0.47 in 2024, then skyrocketed by 98.51% to 0.94 in 2025, then rose by 7.42% to 1.01 in 2026.
  • Business Quant data shows Asset Utilization Ratio for AXSM at 1.01 in Q1 2026, 0.94 in Q4 2025, and 0.68 in Q3 2025.